IFNγ: Signalling, Epigenetics and Roles in Immunity, Metabolism, Disease and Cancer Immunotherapy

Overview

Journal Nat Rev Immunol

Specialty Allergy & Immunology

Date 2018 Jun 21

PMID 29921905

Citations 549

Authors

Lionel B Ivashkiv

Affiliations

Soon will be listed here.

Abstract

IFNγ is a cytokine with important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Signalling by the IFNγ receptor activates the Janus kinase (JAK)-signal transducer and activator of transcription 1 (STAT1) pathway to induce the expression of classical interferon-stimulated genes that have key immune effector functions. This Review focuses on recent advances in our understanding of the transcriptional, chromatin-based and metabolic mechanisms that underlie IFNγ-mediated polarization of macrophages to an 'M1-like' state, which is characterized by increased pro-inflammatory activity and macrophage resistance to tolerogenic and anti-inflammatory factors. In addition, I describe the newly discovered effects of IFNγ on other leukocytes, vascular cells, adipose tissue cells, neurons and tumour cells that have important implications for autoimmunity, metabolic diseases, atherosclerosis, neurological diseases and immune checkpoint blockade cancer therapy.

Citing Articles

IFN-γ signaling links ventriculomegaly to choroid plexus and ependyma dysfunction following maternal immune activation.

Sun Y, Huang X, Guo W, Hong C, Ji J, Zhang X J Neuroinflammation. 2025; 22(1):83.

PMID: 40089736 DOI: 10.1186/s12974-025-03409-3.

Changes in Concentration of Selected Biomarkers of Exposure in Users of Classic Cigarettes, E-Cigarettes, and Heated Tobacco Products-A Narrative Review.

Sniadach J, Kicman A, Michalska-Falkowska A, Jonczyk K, Waszkiewicz N Int J Mol Sci. 2025; 26(5).

PMID: 40076424 PMC: 11898610. DOI: 10.3390/ijms26051796.

The causal relationships between inflammatory cytokines, blood metabolites, and thyroid cancer: a two-step Mendelian randomization analysis.

Liu W, Sun Y, Zhang Y, Yin D Discov Oncol. 2025; 16(1):301.

PMID: 40072746 PMC: 11904021. DOI: 10.1007/s12672-025-02029-w.

Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer.

Guc E, Treveil A, Leach E, Broomfield A, Camera A, Clubley J Nat Commun. 2025; 16(1):2374.

PMID: 40064880 PMC: 11893752. DOI: 10.1038/s41467-025-57470-w.

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.

References

Callahan M, Postow M, Wolchok J . Targeting T Cell Co-receptors for Cancer Therapy. Immunity. 2016; 44(5):1069-78. DOI: 10.1016/j.immuni.2016.04.023. View

Hu X, Chakravarty S, Ivashkiv L . Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev. 2009; 226:41-56. PMC: 2630590. DOI: 10.1111/j.1600-065X.2008.00707.x. View

MHoma Soudja S, Ruiz A, Marie J, Lauvau G . Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity. 2012; 37(3):549-62. PMC: 3456987. DOI: 10.1016/j.immuni.2012.05.029. View

Goldszmid R, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S . NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity. 2012; 36(6):1047-59. PMC: 3412151. DOI: 10.1016/j.immuni.2012.03.026. View

Ip W, Hoshi N, Shouval D, Snapper S, Medzhitov R . Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017; 356(6337):513-519. PMC: 6260791. DOI: 10.1126/science.aal3535. View

Netea M, Joosten L, Latz E, Mills K, Natoli G, Stunnenberg H . Trained immunity: A program of innate immune memory in health and disease. Science. 2016; 352(6284):aaf1098. PMC: 5087274. DOI: 10.1126/science.aaf1098. View

Foster S, Hargreaves D, Medzhitov R . Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007; 447(7147):972-8. DOI: 10.1038/nature05836. View

OSullivan T, Rapp M, Fan X, Weizman O, Bhardwaj P, Adams N . Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance. Immunity. 2016; 45(2):428-41. PMC: 5004886. DOI: 10.1016/j.immuni.2016.06.016. View

Greer R, Dong X, Moraes A, Zielke R, Fernandes G, Peremyslova E . Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nat Commun. 2016; 7:13329. PMC: 5114536. DOI: 10.1038/ncomms13329. View

10.

Molofsky A, Van Gool F, Liang H, Van Dyken S, Nussbaum J, Lee J . Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity. 2015; 43(1):161-74. PMC: 4512852. DOI: 10.1016/j.immuni.2015.05.019. View

11.

McLaren J, Ramji D . Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev. 2008; 20(2):125-35. DOI: 10.1016/j.cytogfr.2008.11.003. View

12.

Parker B, Rautela J, Hertzog P . Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016; 16(3):131-44. DOI: 10.1038/nrc.2016.14. View

13.

Smale S, Tarakhovsky A, Natoli G . Chromatin contributions to the regulation of innate immunity. Annu Rev Immunol. 2014; 32:489-511. DOI: 10.1146/annurev-immunol-031210-101303. View

14.

Ivashkiv L . Epigenetic regulation of macrophage polarization and function. Trends Immunol. 2012; 34(5):216-23. PMC: 3647003. DOI: 10.1016/j.it.2012.11.001. View

15.

Piccolo V, Curina A, Genua M, Ghisletti S, Simonatto M, Sabo A . Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk. Nat Immunol. 2017; 18(5):530-540. PMC: 5524187. DOI: 10.1038/ni.3710. View

16.

Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M . Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017; 546(7658):421-425. PMC: 5482236. DOI: 10.1038/nature22360. View

17.

Tarrant T, Silver P, Wahlsten J, Rizzo L, Chan C, Wiggert B . Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med. 1999; 189(2):219-30. PMC: 2192986. DOI: 10.1084/jem.189.2.219. View

18.

Peng W, Liu C, Xu C, Lou Y, Chen J, Yang Y . PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines. Cancer Res. 2012; 72(20):5209-18. PMC: 3476734. DOI: 10.1158/0008-5472.CAN-12-1187. View

19.

Kreutzfeldt M, Bergthaler A, Fernandez M, Bruck W, Steinbach K, Vorm M . Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss. J Exp Med. 2013; 210(10):2087-103. PMC: 3782053. DOI: 10.1084/jem.20122143. View

20.

Weizman O, Adams N, Schuster I, Krishna C, Pritykin Y, Lau C . ILC1 Confer Early Host Protection at Initial Sites of Viral Infection. Cell. 2017; 171(4):795-808.e12. PMC: 5687850. DOI: 10.1016/j.cell.2017.09.052. View